Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study

Gareri Pietro; Putignano Daria; Castagna Alberto; Cotroneo Antonino Maria; De Palo Grazia; Fabbo Andrea; Forgione Luigi; Giacummo Attilio; Lacava Roberto; Marino Saverio; Simone Maurizio; Zurlo Amedeo; Putignano Salvatore

首页> 外文期刊>Journal of Alzheimer's disease: JAD >Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study

【24h】

Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study

机译：美金刚和胆碱酯酶抑制剂联合治疗对老年痴呆症老年患者的益处的回顾性研究：MEMAGE研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Combined therapy of memantine and acetylcholinesterase inhibitors (AChEIs) in patients with Alzheimer's disease (AD) may be associated with higher benefits than either monotherapy.

机译：背景：在阿尔茨海默氏病（AD）患者中，美金刚和乙酰胆碱酯酶抑制剂（AChEIs）的联合治疗可能比单药治疗具有更高的获益。

著录项

来源
《Journal of Alzheimer's disease: JAD 》 |2014年第2期| 共8页
作者
Gareri Pietro; Putignano Daria; Castagna Alberto; Cotroneo Antonino Maria; De Palo Grazia; Fabbo Andrea; Forgione Luigi; Giacummo Attilio; Lacava Roberto; Marino Saverio; Simone Maurizio; Zurlo Amedeo; Putignano Salvatore;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学 ;
关键词
Alzheimer's disease; acetylcholinesterase inhibitor drugs; elderly; memantine;

机译：阿尔茨海默氏病;乙酰胆碱酯酶抑制剂;老年人;美金刚;

相似文献

外文文献
中文文献
专利

1. Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study [J] . Gareri Pietro, Putignano Daria, Castagna Alberto, Journal of Alzheimer's disease: JAD . 2014 ,第2期

机译：美金刚和胆碱酯酶抑制剂联合治疗对老年痴呆症老年患者的益处的回顾性研究：MEMAGE研究
2. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease [J] . GauthierS., MolinuevoJ.L. Alzheimer’s & dementia: the journal of the Alzheimer’s Association . 2013 ,第3期

机译：胆碱酯酶抑制剂联合美金刚治疗中度重度阿尔茨海默氏病的益处
3. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. [J] . Dantoine T, Auriacombe S, Sarazin M, International journal of clinical practice . 2006 ,第1期

机译：利凡芯单药治疗和组合治疗患者中度严重的阿尔茨海默病患者未能受益于先前的胆碱酯酶抑制剂治疗。
4. Improving adherence and persistence to cholinesterase inhibitor therapy in Alzheimer's disease: development of the CaretoCare? caregiver support program [C] . Brady R., Walburn J., Weinman J., International Conference of Alzheimer's Disease International . 2012

机译：在阿尔茨海默病的胆碱酯酶抑制剂治疗中提高依从性和持续性：Caretocare的发展？护理人员支持计划
5. A Retrospective Study of Cholinesterase Inhibitors for Alzheimer's Disease: The Effect of Cerebrovascular Disease on Patient Outcomes and the Impact of Biases on the Results. [D] . Charbonneau, Claudie. 2011

机译：胆碱酯酶抑制剂对阿尔茨海默氏病的回顾性研究：脑血管疾病对患者结果的影响以及偏见对结果的影响。
6. The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double-blind, placebo-controlled trial [O] . Christopher L.H. Chen, Purabi Reang Sharma, Boon Yeow Tan, 2015

机译：NEuroaid（ATHENE）研究阿尔茨海默氏病的研究方案：评估神经碱II（MLC901）在胆碱酯酶抑制剂或美金刚稳定的轻度至中度阿尔茨海默氏病患者中的安全性和有效性-随机，双盲，安慰剂对照试用
7. The A lzheimer's disease THE rapy with NE uroaid ( ATHENE ) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild‐to‐moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine—A randomized, double‐blind, placebo‐controlled trial [O] . Christopher L.H. Chen, Purabi Reang Sharma, Boon Yeow Tan, 2019

机译：Lzheimer的疾病与Ne Uroaid（Athene）的研究方案的脱脂剂：评估神经外套II（MLC901）在胆碱酯酶抑制剂或Memantine-A随机的双盲患者稳定的患者中神经外套II（MLC901）的安全性和有效性安慰剂对照试验

Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study

摘要

著录项

相似文献

相关主题

期刊订阅